Search by Drug Name or NDC

    NDC 10122-0180-02 Lamzede 10 mg/1 Details

    Lamzede 10 mg/1

    Lamzede is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chiesi USA, Inc.. The primary component is VELMANASE ALFA-TYCV.

    Product Information

    NDC 10122-0180
    Product ID 10122-180_27cf090b-196e-4330-8184-c72d9bb90660
    Associated GPIs
    GCN Sequence Number 080623
    GCN Sequence Number Description velmanase alfa-tycv VIAL 10 MG INTRAVEN
    HIC3 Z1X
    HIC3 Description METABOLIC DX ENZYME REPLACEMENT,ALPHA-MANNOSIDOSIS
    GCN 47541
    HICL Sequence Number 046263
    HICL Sequence Number Description VELMANASE ALFA-TYCV
    Brand/Generic Brand
    Proprietary Name Lamzede
    Proprietary Name Suffix n/a
    Non-Proprietary Name Velmanase alfa-tycv
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name VELMANASE ALFA-TYCV
    Labeler Name Chiesi USA, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761278
    Listing Certified Through 2024-12-31

    Package

    NDC 10122-0180-02 (10122018002)

    NDC Package Code 10122-180-02
    Billing NDC 10122018002
    Package 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-02)
    Marketing Start Date 2023-03-01
    NDC Exclude Flag N
    Pricing Information N/A